| |
Click here to see more photographs from the Milner Therapeutics Symposium 2019
|
| |
 |
|
Summer Announcements: July 2019
|
|
|
|
|
| |
Thank you to all who attended the Milner Therapeutics Symposium on June 25th at the Cambridge Corn Exchange and helped make the day a fantastic success. This was the largest symposium to date with over 500 attendees and parallel tracks on oncology, CNS therapeutics, anti-microbial resistance & the microbiome, and cardiovascular & metabolism. With speakers across computational biology, chemistry and engineering, the event highlighted interdisciplinary advances in biomedical research. We were particularly excited to have a full house in the last session to hear from Jonathan Milner and Jason Mellad, CEO of the new Start Codon accelerator, on investment opportunities in Cambridge.
Photographs from the event can be found by clicking the images above - see if you cant spot anyone you know! If you have not already completed the Symposium survey, please take 2 minutes to complete this before August 1st. Your feedback is very useful for shaping future events. Click here »
Renewal of Milner Therapeutics Consortium
We are delighted to announce that the Milner Therapeutics Consortium has been renewed until 2024. The Consortium includes 7 pharma companies (Astex, AstraZeneca, Ferring, GlaxoSmithKline, J & J Innovation, Pfizer, Shionogi) who are committed to collaboration and research investment in Cambridge academic institutes. "The renewal of this Consortium is a fantastic opportunity for the Milner and Cambridge researchers to make significant progress towards our goal of transforming pioneering science into therapies. It reflects the strong commitment of these companies to innovative collaborations with academics that add value through combined resource and complementary expertise. It is particularly exciting that this coincides with the opening of the Milner Therapeutics Institute this summer, providing a physical hub for these partnerships” says our Director Tony Kouzarides.
Please visit our website to learn more about how to engage with us »
|
|
|
|
|
|
| |
|
|
Local Events
|
|
|
|
|
| |
 |
MedTechBoost
2nd - 6th September, Cambridge
This September, the week long MedTechBoost will blend PhD & Post-Doc students and startups, combined with key people at EAHSN, and take them through a structured process of practical ideation, venture development, and lean solution-design, to create and develop ground-breaking new solutions for the NHS. Apply by July 31st.
Read more »
|
|
Wellcome Genome Campus Conference: CRISPR and beyond - perturbations at scale to understand genomes
2nd - 4th September, Cambridge
A focus on ways to modulate genomes at scale, and to record the result. The sessions cover per-locus approaches (experiments for coding and non-coding variant interpretation), as well as genome-wide ones (screens in cells and organisms), more complex designs (gene-gene, gene-variant, gene-drug, gene-environment interactions), and two technology sessions.
Read more »
|
|
CeBIL Annual Symposium 2019: Legal Innovation to Support the Development of Anti-Microbial Drugs
6th September, Cambridge
Antimicrobial resistance continues to expand, raising the risk of a future public health crisis. This symposium, organized by the Cambridge Centre for Law, Medicine and Life Sciences, the Center for Advanced Studies in Biomedical Innovation Law at the University of Copenhagen, explores the complex interactions between law and antimicrobial research and development in order to advance our understanding of this ecosystem. It is hoped that the event will mobilize legal, economic, business, medical and scientific experts – early, mid, and late career – who recognize the need to work together to both promote antimicrobial innovation and limit the impact of antimicrobial resistance on global health.
Read more »
|
|
Cambridge New Therapeutics Forum (CamNTF) September Meeting
11th September, Cambridge
The CamNTF forum promotes interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development. Meeting attendance is free but all attendees must register in advance. This fifth seminar in the series will be hosted by AstraZeneca.
Read more »
|
|
First International RNA Epigenetics in Human Disease Conference
17th - 20th September, Cambridge
This meeting is sponsored by STORM Therapeutics and organised by Eric Miska and Tony Kouzarides, Gurdon Institute and STORM Therapeutics.
Read more »
|
|
Chemistry Networks: Focus on AI & Machine Learning
25th September, Cambridge
The Department of Chemistry, University of Cambridge, invites you to attend its annual industry networking and showcase event. Chemistry Networks is an opportunity for scientists from academia and industry to discuss their latest research, discover overlapping interests and identify collaborative opportunities. Read more »
|
|
|
|
|
| |
